procedure treatment of dianion 1 (4 mmol) with 2-(benzyloxy)-
1-naphthaldehyde (1.15 g, 4.4 mmol) yielded the alcohol 22a as
a pale yellow, crystalline solid (1.10 g, 55%), mp 94–97 ЊC
(ether–pentane), νmax/cmϪ1 3256, 3062, 2948, 2926, 2848, 1748,
1625, 1596, 1513, 1454, 1370, 1252, 1157, 1085, 1021, 911, 816,
734 and 697; δH 1.47 (9H, s, C(CH3)3), 5.12 (1H, d, J 11.5,
CHaAr), 5.18 (1H, d, J 11.5, CHbAr), 6.66 (1H, d, J 7.2,
CHOH), 6.93 (1H, d, J 10, Ar-H), 7.00–7.07 (3H, m, 3 × Ar-
H), 7.15–7.20 (3H, m, 3 × Ar-H), 7.28–7.32 (2H, m, 2 × Ar-H),
7.38 (1H, d, J 8.0, Ar-H), 7.61–7.65 (1H, m, Ar-H), 7.78–7.82
(1H, m, Ar-H), 7.88 (1H, d, J 8.0, Ar-H), 7.93 (1H, d, J 8.3,
Ar-H) and 8.90 (1H, s, NH); δC 28.5 (C(CH3)3), 68.4 (CHOH),
72.0 (CH2), 83.9 (C(CH3)3), 114.9 (CH), 120.2 (C), 120.9 (CH),
122.9 (C), 124.4, 124.8 (both CH), 126.3 (C), 126.9, 127.9,
128.9, 129.1 (all CH), 129.2, 129.8 (both C), 131.1 (CH), 132.3,
lation procedure for 18 h to yield the tetrahydronaphthol 25 as a
colourless solid (0.31 g, 79%), mp 102–103 ЊC, νmax/cmϪ1 3254,
2976, 2934, 2862, 1724, 1592, 1488, 1455, 1395, 1370, 1253,
1158, 1056, 1019, 910, 812 and 733; δH 1.20–1.55 (9H, br s,
C(CH3)3), 1.60–1.70 (4H, br res, 2 × CH2), 2.35–2.40 (2H, br
res, CH2), 2.65–2.72 (2H, br res, CH2), 4.15–4.20 (2H, br res,
Ar2CH2), 6.55 (1H, br d, J ∼8, Ar-H), 6.60 (1H, br d, J ∼8,
Ar-H), 6.78 (1H, br d, J ∼8, 6-H), 6.98 (1H, br t, J ∼8, 5-H),
7.52 (1H, br d, J ∼8, 4-H) and 8.80–8.95 (1H, br s, NH); δC 22.9,
23.2, 25.0 and 26.6 (all CH2), 28.1 (C(CH3)3), 29.6 (CH2), 83.9
(C(CH3)3), 113.4, 117.7 (both CH), 122.1, 123.7 (both C), 125.0,
126.8, 128.8 (all CH), 129.8, 131.1, 137.2, 144.4, 152.3 (all C)
and 153.9 (C᎐O); m/z (APcI) 395 (Mϩ ϩ 1, 100%) and 339 (20)
᎐
[Found: C, 66.68; H, 6.88; N, 14.14. C22H26N4O3 requires C,
66.97; H, 6.65; N, 14.21%].
135.9, 146.1 (all C) and 155.2 (C᎐O) (3 × CH resonances
᎐
coincidental); m/z (ES) 497 (Mϩ ϩ 1, 100%) [Found: C, 70.39;
H, 5.80; N, 11.41. C29H28N4O4 requires C, 70.13; H, 5.69; N,
11.29%].
6,8- and 6,9-Diiodo-1,2,3,4-tetrahydro-12H-benzo[a]xanthene
26 and 27. Benzotriazole 25 (0.40 g, 1.0 mmol) was subjected
to the general deprotection–cyclisation protocol to yield the
xanthenes 26 and 27 (0.27 g, 77%) as an approximately 1 : 1
mixture. A sample of the 6,8-diiodide 26 was separated by
fractional crystallization from dichloromethane–petrol and
showed mp 87–89 ЊC, δH 1.72–1.79 (2H, br m, 8-CH2), 1.83–
1.91 (2H, br m, 9-CH2), 2.61 (2H, br app. t, J 6.5, 7-CH2), 2.72
(2H, br app. t, J 6.3, 10-CH2), 3.90 (2H, s, CH2Ar2), 6.79 (1H, t,
J 7.7, 2-H), 7.16 (1H, d, J 7.7, 1-H), 7.48 (1H, s, 6-H) and 7.69
(1H, d, J, 7.7, 3-H); δC 21.4, 21.8, 25.2, 25.3, 28.1 (all CH2),
79.7, 83.2 (both C-I), 112.9 (C), 123.7 (CH), 124.8, 127.2 (both
C), 127.9 (CH), 128.3 (C), 136.8, 136.8 (both CH), 147.9 and
150.3 (both C); m/z (APcI) 489 (Mϩ ϩ 1, 100%).
1-(tert-Butoxycarbonylamino)-7-[(2-hydroxy-1-naphthyl)-
methyl]-1H-benzotriazole 22b. Benzotriazole 22a (0.43 g, 0.87
mmol) was subjected to the general hydrogenation procedure
to yield naphthol 22b as a colourless solid (0.28 g, 82%), mp
117–120 ЊC, νmax/cmϪ1 3263, 3062, 2984, 2833, 1720, 1629, 1513,
1439, 1370, 1272, 1252, 1157, 993, 909, 815 and 733; δH (323 K)
1.51–1.59 (9H, br s, C(CH3)3), 4.83 (2H, s, CH2Ar2), 6.00–6.30
(1H, br s, OH), 6.75 (1H, d, J 7.2, Ar-H), 7.01 (1H, t, J 7.6,
5-H), 7.20 (1H, d, J 7.6, 6-H), 7.35 (1H, t, J 7.9, Ar-H), 7.41
(1H, t, J 7.9, Ar-H), 7.70 (1H, d, J 7.6, Ar-H), 7.78 (2H, d, J 8.8,
2 × Ar-H), 7.84 (1H, d, J 7.6, 4-H) and 8.68–8.72 (1H, br s,
NH); δC 23.0 (CH2), 28.5 (C(CH3)3), 84.7 (C(CH3)3), 115.7 (C),
118.6, 123.4, 123.7 (all CH), 123.8, 124.4 (both C), 125.5, 128.2,
129.0, 129.5 (all CH), 129.7, 131.2, 134.1, 144.7 (all C) and
From spectra of the mixture, the 6,9-diiodide 27 showed δH
1.72–1.79 (2H, br m, 8-CH2), 1.83–1.91 (2H, br m, 9-CH2), 2.65
(2H, br app. t, J 6.5, 7-CH2), 2.77 (2H, br app. t, J 6.3, 10-CH2),
3.90 (2H, s, CH2Ar2), 6.75 (1H, t, J 7.7, 2-H), 6.99 (1H, s, 6-H),
7.16 (1H, d, J 7.7, 1H) and 7.62 (1H, d, J 7.7, 3-H).
152.5 (C᎐O) (2 × CH coincidental); m/z (APcI) 391 (Mϩ ϩ 1,
᎐
100%) [Found: C, 67.31; H, 5.42. C22H22N4O3 requires C, 67.66;
H, 5.68%].
1-(tert-Butoxycarbonylamino)-7-[1-(2-benzyloxyphenyl)-1-
hydroxyethyl]-1H-benzotriazole 29a. Following the general
procedure, treatment of dianion 1 (5 mmol) with 2-(benzyl-
oxy)acetophenone 28 (1.24 g, 5.5 mmol) yielded the alcohol 29a
as a beige, crystalline solid (1.65 g, 72%), mp 67–68 ЊC (ether–
petrol), νmax/cmϪ1 3279, 3062, 2980, 2933, 1753, 1600, 1488,
1453, 1370, 1252, 1159, 1052, 911, 806, 751 and 699; δH 1.25–
1.56 (9H, br s, C(CH3)3), 2.05 (3H, s, 1Ј-Me), 4.82–4.91 (1H, br
app. s, CHaAr), 4.95–5.05 (1H, br res., CHbAr), 5.32–5.40 (1H,
br s, OH), 6.72–7.32 (10H, br res., 10 × Ar-H), 7.40 (1H, t,
J 7.7, Ar-H), 8.05 (1H, d, J 8.4, 4-H) and 9.10–9.42 (1H, br s,
NH); δH (323 K) 1.40–1.45 (9H, br s, C(CH3)3), 2.05 (3H, s,
1Ј-Me), 4.90 (1H, br d, J ∼10, CHaAr), 5.02 (1H, br d, J ∼10,
CHbAr), 5.27 (1H, s, OH), 6.80–6.92 (2H, br res, 2 × Ar-H),
7.01 (1H, t, J 7.5, 5-H), 7.09 (1H, d, J 7.5, 6-H), 7.11–7.19 (2H,
m, 2 × Ar-H), 7.20–7.27 (4H, m, 4 × Ar-H), 7.36 (1H, t, J 8.2,
Ar-H), 8.04 (1H, d, J 7.5, 4-H) and 8.81–9.00 (1H, br s, NH);
δC 28.5 (C(CH3)3), 29.3 (CH3), 71.3 (CH2), 77.9 (MeCOH), 83.2
(C(CH3)3), 113.6, 120.6, 122.0, 124.2, 126.1, 127.8, 129.0, 129.1
(all CH), 129.7 (C), 130.1 (CH), 134.0, 135.6, 141.1, 146.8,
8-Iodo-12H-benzo[a]xanthene 23. Benzotriazole 22b (0.12 g,
0.31 mmol) was subjected to the deprotection–cyclisation
protocol to yield the xanthene 23 (0.08 g, 75%), mp 131–133 ЊC,
νmax/cmϪ1 3062, 2962, 2926, 2855, 1645, 1595, 1437, 1252, 1066
and 816; δH 4.33 (2H, s, CH2Ar2), 6.77 (1H, t, J 7.6, 10-H), 7.22
(1H, dd, J 7.5 and 7.5, 5-H), 7.31 (1H, d, J 7.6, 9-H), 7.39 (1H,
t, J 7.1, 4-H), 7.52 (1H, t, J 7.1, 3-H), 7.64 (1H, d, J 8.3, 6-H),
7.70 (1H, d, J 8.3, 7-H) and 7.77–7.81 (2H, m, 2- and 11-H);
δC 29.4 (CH2), 81.2 (C-I), 117.0, 117.1 (both CH), 122.3 (C),
123.6, 124.8 (both CH), 125.2 (C), 126.2, 127.4, 127.5, 127.5 (all
CH), 128.8, 129.1 (both C), 136.1 (CH), 136.7 and 142.1 (both
C); m/z (APcI) 360 (Mϩ ϩ 2, 24%) and 356 (100) [Found: C,
57.11; H, 3.26. C17H11IO requires C, 56.99; H, 3.10%].
8-Iodo-12H-benzo[a]xanthen-12-one 24. Benzotriazole 22b
(0.12 g, 0.31 mmol) was subjected to the deprotection–
cyclisation protocol and the solution allowed to stir for an
additional 1 h before workup, as before, to yield the xanthone 24
as a beige, crystalline solid (0.09 g, 84%) (1H NMR showed
essentially quantitative conversion), mp 110–112 ЊC, νmax/cmϪ1
2962, 2926, 2855, 1781, 1644, 1452, 1373, 1337, 1258, 1223,
1158, 1044 and 808; δH 6.73 (1H, d, J 8.2, 5-H), 7.36 (1H, t,
J 7.7, 10-H), 7.74–7.85 (3H, m, 3-, 4- and 7-H), 8.20 (1H, d,
J 7.7, 11-H), 8.60 (1H, d, J 7.7, 9-H), 8.79 (1H, s, 6-H) and
10.21 (1H, d, J 8.2, 2-H); δC 92.1 (C-I), 126.5 (CH), 128.4, 128.9
(both C), 129.4, 129.6, 129.7 (all CH), 130.2, 131.4 (both C),
132.4, 134.5 (both CH), 135.0, 137.7 (both C), 136.0, 147.6
151.9 (all C) and 156.2 (C᎐O); m/z (APcI) 461 (Mϩ ϩ 1, 100%)
᎐
[Found: C, 67.98; H, 6.21; N, 12.20. C26H28N4O4 requires C,
67.79; H, 6.13; N, 12.17%].
1-(tert-Butoxycarbonylamino)-7-[1-hydroxy-1-(2-hydroxy-
phenyl)ethyl]-1H-benzotriazole 29b. Benzotriazole 29a (0.46 g,
1.0 mmol) was subjected to the general hydrogenation pro-
cedure to yield the phenol 29b as a colourless solid (0.29 g,
79%), mp 102–103 ЊC, νmax/cmϪ1 3279, 2976, 1713, 1581, 1496,
1366, 1287, 1225, 1151, 901, 808 and 743; δH 1.16–1.50 (9H, br
s, C(CH3)3), 1.97–2.02 (3H, s, Me), 6.05–6.12 (1H, br d, J ∼7,
6Љ-H), 6.38–6.49 (1H, br t, J ∼7, 5Љ-H), 6.82–6.90 (1H, br d,
J ∼8, 6-H), 7.02–7.11 (1H, br t, J ∼8, 5-H), 7.13–7.25 (1H, br t,
J ∼7, 4Љ-H), 7.35–7.42 (1H, br d, J ∼7, 3Љ-H), 7.57–7.71 (1H, br
(both CH) and 183.2 (C᎐O) (one C obscured).
᎐
1-(tert-Butoxycarbonylamino)-7-[(2-hydroxy-5,6,7,8-tetra-
hydro-1-naphthyl)methyl]-1H-benzotriazole 25. Benzotriazole
22a (0.50 g, 1.0 mmol) was subjected to the general dehydroxy-
1776
J. Chem. Soc., Perkin Trans. 1, 2001, 1771–1777